Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
172,863
-
Shares change
-
+39,523
-
Total reported value, excl. options
-
$17,292,257
-
Value change
-
+$3,960,918
-
Put/Call ratio
-
163%
-
Number of buys
-
12
-
Number of sells
-
-4
-
Price
-
$100.01
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q2 2023
27 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q2 2023.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 172,863 shares
.
Largest 10 shareholders include Bullseye Investment Management, LLC (44,232 shares), CITADEL ADVISORS LLC (27,741 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (23,470 shares), GTS SECURITIES LLC (22,975 shares), GOLDMAN SACHS GROUP INC (19,801 shares), Virtu Financial LLC (11,793 shares), Traynor Capital Management, Inc. (8,323 shares), JANE STREET GROUP, LLC (4,297 shares), Tower Research Capital LLC (TRC) (3,808 shares), and Onyx Bridge Wealth Group LLC (2,396 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.